| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0021 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.0094 | 1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |